Cellect Biotechnology Ltd. Form 6-K Summary
Business Context and Reporting Period
This Form 6-K was filed by Cellect Biotechnology Ltd. (a foreign private issuer) on June 12, 2017. The filing serves to distribute a press release issued on the same date regarding a regulatory milestone. Note: The request metadata references "Quoin Pharmaceuticals, Ltd.", but the filing text explicitly identifies the registrant as "Cellect Biotechnology Ltd."
Key Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This document is a current report of a material event and does not contain financial statements or performance data.
Material Changes
The material event reported is the receipt of a Notice of Allowance from the United States Patent and Trademark Office (USPTO) for a patent application. This represents a significant intellectual property milestone for the company.
Guidance, Outlook, and Risks
The filing does not contain financial guidance, management commentary on future performance, or a discussion of risks and contingencies beyond the context of the patent allowance. No unusual items were reported.
Investor Verification Checklist
- Verify the specific patent number and scope of the Notice of Allowance referenced in the attached press release (Exhibit 99.1).
- Confirm the company's current cash position and runway, as this filing does not disclose financial status.
- Review the company's most recent Form 20-F for comprehensive financial data and risk factors.